前往 An Efficacy and Safety Study for Rivaroxaban in Patients With ...
常見Atlas 2 trial問答
Rivaroxaban nejmTimi 46ATLAS ACS 2 TIMI 51Low dose rivaroxaban nejmAUGUSTUS trialAPPRAISE 2compass trialPIONEER AF-PCICabenuva press releaseAtlas PluginsXO vs Atlas 2Swindells s et al n engl j med 2020 382 1112 23Atlas VST plugin Free DownloadAlgonaut atlas twitterAtlas 2.0 VSTAlgonaut Atlas 2 review
延伸文章資訊The ATLAS ACS 2–TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovas...
... (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial ... Three patients in stratum...
These percentages differ greatly from the ATLAS ACS‐2 TIMI 51 trial at large (24% unstable angina...
ATLAS ACS 2-TIMI 51 was a phase III, multicenter, randomized, double-blind, placebo-controlled cl...
The phase II ATLAS ACS–TIMI 46 trial noted that in patients with recent acute coronary syndrome (...
Design · Multicenter, double-blind, parallel group, randomized, placebo-controlled trial · N=15,3...
Objectives and methods:: ATLAS ACS 2-TIMI 51 was a double-blind, placebo-controlled clinical tria...
The ATLAS ACS 2–TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovas...
... (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial ... Three patients in stratum...
These percentages differ greatly from the ATLAS ACS‐2 TIMI 51 trial at large (24% unstable angina...
ATLAS ACS 2-TIMI 51 was a phase III, multicenter, randomized, double-blind, placebo-controlled cl...
The phase II ATLAS ACS–TIMI 46 trial noted that in patients with recent acute coronary syndrome (...
Design · Multicenter, double-blind, parallel group, randomized, placebo-controlled trial · N=15,3...
Objectives and methods:: ATLAS ACS 2-TIMI 51 was a double-blind, placebo-controlled clinical tria...